Trial · NCT01445873
Results by group44
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 44
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patterns of Pharmacotherapy With Sitaxentan Sodium (Thelin): Mean Time to Therapy Augmentation | Sitaxentan (Thelin) | 2.2 | Standard Deviation 1.2 | months | |
| Patterns of Pharmacotherapy With Sitaxentan Sodium (Thelin): Therapy Switching | Sitaxentan (Thelin) | 0 | participants | ||
| Patterns of Pharmacotherapy With Sitaxentan Sodium (Thelin): Therapy Discontinuation | Sitaxentan (Thelin) | 0 | participants | ||
| Patterns of Pharmacotherapy With Sitaxentan Sodium (Thelin): Therapy Duration | Sitaxentan (Thelin) | 6 | Standard Deviation 0 | months | |
| Patterns of Pharmacotherapy With Sitaxentan Sodium (Thelin): Daily Dosage | Sitaxentan (Thelin) | 100.0 | 95% Confidence Interval 100.0 to 100.0 | mg | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Anticoagulants | 83.3 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Diuretics | 88.9 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Calcium channel blockers | 22.2 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Digoxin | 5.6 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Supplemental oxygen | 44.4 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Prostanoids | 27.8 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Other endothelin receptor antagonists | 0.0 | percentage of participants | |
| Use of Other Pulmonary Arterial Hypertension (PAH)-Related Medications | Sitaxentan (Thelin) | Phosphodiesterase-5 inhibitors | 47.2 | percentage of participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) I to FC I | 0 | participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) I to FC II | 0 | participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) I to FC III | 0 | participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) I to FC IV | 0 | participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) II to FC I | 0 | participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) II to FC II | 1 | participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class of Pulmonary Hypertension | Sitaxentan (Thelin) | Pre-index functional class (FC) II to FC III | 2 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01445873/results